Drug shortage: Quinapril/Hydrochlorothiazide Tablet (QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE, QUINAPRIL AND HYDROCHLOROTHIAZIDE)
FDA lists 6 presentations as Current. Availability: Unavailable (3), Available (3). Reason: Discontinuation of the manufacture of the drug. Companies: Aurobindo Pharma USA, Chartwell Molecular Holdings LLC.
- Published by source
- 2023-01-19
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Aurobindo Pharma USA
- Products
- Quinapril/Hydrochlorothiazide Tablet QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE QUINAPRIL AND HYDROCHLOROTHIAZIDE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-01-19
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #910 | new | 2026-10-22 | b3a9de156c76…db32ae | ff795f50728e…7962b0 |
Chain head: #1094 edf3be25ec2e…478842